McNulty Alana B.

McNulty Alana B. is listed in filings as Director at Janux Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 13, 2025, including 4 public disclosures. Recent filings connect the profile to Janux Therapeutics, Inc. (JANX). The current snapshot covers public activity from Jun 28, 2024 to Jun 13, 2025. Reported amounts are shown as $332.3K to $297.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.